These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25248738)

  • 1. [Antibiotics in low- and middle-income countries].
    Wertheim HF; Schultsz C
    Ned Tijdschr Geneeskd; 2014; 158():A8049. PubMed ID: 25248738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibiotic resistance--action to promote new technologies: report of an EU Intergovernmental Conference held in Birmingham, UK, 12-13 December 2005.
    Finch R; Hunter PA
    J Antimicrob Chemother; 2006 Sep; 58 Suppl 1():i3-i22. PubMed ID: 17003063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using 'smart regulation' to tackle antimicrobial resistance in low-income and middle-income countries.
    Porter G; Joshi J; Bhullar L; Kotwani A;
    BMJ Glob Health; 2020; 5(1):e001864. PubMed ID: 32133168
    [No Abstract]   [Full Text] [Related]  

  • 4. Combating antibiotic resistance: The role of nursing in antibiotic stewardship.
    Manning ML; Pfeiffer J; Larson EL
    Am J Infect Control; 2016 Dec; 44(12):1454-1457. PubMed ID: 27592161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial Heterogeneity and Antibiotic Survival: Understanding and Combatting Persistence and Heteroresistance.
    Dewachter L; Fauvart M; Michiels J
    Mol Cell; 2019 Oct; 76(2):255-267. PubMed ID: 31626749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global need for effective antibiotics-moving towards concerted action.
    Cars O; Hedin A; Heddini A
    Drug Resist Updat; 2011 Apr; 14(2):68-9. PubMed ID: 21444235
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance.
    Mölstad S; Löfmark S; Carlin K; Erntell M; Aspevall O; Blad L; Hanberger H; Hedin K; Hellman J; Norman C; Skoog G; Stålsby-Lundborg C; Tegmark Wisell K; Åhrén C; Cars O
    Bull World Health Organ; 2017 Nov; 95(11):764-773. PubMed ID: 29147057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics approach to understand bacterial antibiotic resistance strategies.
    Peng B; Li H; Peng X
    Expert Rev Proteomics; 2019 Oct; 16(10):829-839. PubMed ID: 31618606
    [No Abstract]   [Full Text] [Related]  

  • 9. Novel antibiotics: are we still in the pre-post-antibiotic era?
    Draenert R; Seybold U; Grützner E; Bogner JR
    Infection; 2015 Apr; 43(2):145-51. PubMed ID: 25701222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic Resistance: The Need For a Global Strategy.
    Elder DP; Kuentz M; Holm R
    J Pharm Sci; 2016 Aug; 105(8):2278-87. PubMed ID: 27397433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Maxwell Finland Lecture: for the duration-rational antibiotic administration in an era of antimicrobial resistance and clostridium difficile.
    Rice LB
    Clin Infect Dis; 2008 Feb; 46(4):491-6. PubMed ID: 18194098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview: Global and Local Impact of Antibiotic Resistance.
    Watkins RR; Bonomo RA
    Infect Dis Clin North Am; 2016 Jun; 30(2):313-322. PubMed ID: 27208761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can better prescribing turn the tide of resistance?
    Livermore D
    Nat Rev Microbiol; 2004 Jan; 2(1):73-8. PubMed ID: 15035011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of antimicrobial stewardship programs in the control of bacterial resistance].
    Pasquau J; Sadyrbaeva S; De Jesús SE; Hidalgo-Tenorio C
    Rev Esp Quimioter; 2016 Sep; 29 Suppl 1():47-51. PubMed ID: 27608314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic therapy: progress and development of resistance].
    Adam D
    Internist (Berl); 2006 Jul; 47(7):758-63. PubMed ID: 16703381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combating antibiotic resistance, mitigating future threats and ongoing initiatives.
    Velez R; Sloand E
    J Clin Nurs; 2016 Jul; 25(13-14):1886-9. PubMed ID: 26991135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Designing drugs that overcome antibacterial resistance: where do we stand and what should we do?
    Penchovsky R; Traykovska M
    Expert Opin Drug Discov; 2015 Jun; 10(6):631-50. PubMed ID: 25981754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Appropriate antibiotic use and why it is important: the challenges of bacterial resistance.
    Lieberman JM
    Pediatr Infect Dis J; 2003 Dec; 22(12):1143-51. PubMed ID: 14688589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The First Global Forum on Bacterial Infections calls for urgent action to contain antibiotic resistance.
    Vlieghe E
    Expert Rev Anti Infect Ther; 2012 Feb; 10(2):145-8. PubMed ID: 22339188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A framework for global surveillance of antibiotic resistance.
    Grundmann H; Klugman KP; Walsh T; Ramon-Pardo P; Sigauque B; Khan W; Laxminarayan R; Heddini A; Stelling J
    Drug Resist Updat; 2011 Apr; 14(2):79-87. PubMed ID: 21482177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.